Genomic analyses of primary and metastatic serous epithelial ovarian cancer

被引:27
作者
Israeli, O
Gotlieb, WH
Friedman, E
Korach, J
Friedman, E
Goldman, B
Zeltser, A
Ben-Baruch, G
Rienstein, S
Aviram-Goldring, A [1 ]
机构
[1] Chaim Sheba Med Ctr, Danek Gertner Inst Human Genet, IL-52621 Tel Hashomer, Ramat Gan, Israel
[2] Chaim Sheba Med Ctr, Susanne Levy Gertner Oncogenet Unit, IL-52621 Tel Hashomer, Ramat Gan, Israel
[3] Chaim Sheba Med Ctr, Dept Gynecol Oncol, IL-52621 Tel Hashomer, Ramat Gan, Israel
[4] Chaim Sheba Med Ctr, Dept Pathol, IL-52621 Tel Hashomer, Ramat Gan, Israel
关键词
D O I
10.1016/j.cancergencyto.2004.02.006
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Epithelial ovarian cancer is the most lethal gynecologic malignancy in the western world. In 75% of patients, peritoneal metastases are found at the time of primary surgery. However, the genetic events leading to the development of ovarian tumors and to the genetic progression toward metastasis remain unclear. To gain insight into this issue, the types and patterns of DNA copy number changes were compared between primary ovarian tumors and their respective metastases by using comparative genomic hybridization (CGH) and fluorescence in situ hybridization (FISH). The genetic alterations (deletions and amplifications) detected by CGH were similar in the primary tumors and in their respective metastases. Moreover, the FISH results show a similar pattern of chromosomal abnormalities. Our results imply that the major gross genetic changes in ovarian cancer take place in the primary tumor, and the additional genetic changes that may occur in the metastases are not detectable by CGH. (C) 2004 Elsevier Inc. All rights reserved.
引用
收藏
页码:16 / 21
页数:6
相关论文
共 25 条
[1]  
*AM CANC SOC, 2002, CANC FACTS FIG
[2]   Chromosomal aberrations in colorectal cancers and liver metastases analyzed by comparative genomic hybridization [J].
Aragane, H ;
Sakakura, C ;
Nakanishi, M ;
Yasuoka, R ;
Fujita, Y ;
Taniguchi, H ;
Hagiwara, A ;
Yamaguchi, T ;
Abe, T ;
Inazawa, J ;
Yamagishi, H .
INTERNATIONAL JOURNAL OF CANCER, 2001, 94 (05) :623-629
[3]   Genetic evolution in the metastatic progression of human pancreatic cancer studied by CGH [J].
Armengol, G ;
Capellà, G ;
Farré, L ;
Peinado, MA ;
Miró, R ;
Caballin, MR .
LABORATORY INVESTIGATION, 2001, 81 (12) :1703-1707
[4]  
Auersperg N, 1997, J CELL PHYSIOL, V173, P261, DOI 10.1002/(SICI)1097-4652(199711)173:2<261::AID-JCP32>3.0.CO
[5]  
2-G
[6]   Chromosomal imbalances in primary and metastatic melanomas revealed by comparative genomic hybridization [J].
Balázs, M ;
Adám, Z ;
Treszl, A ;
Bégány, A ;
Hunyadi, J ;
Adány, R .
CYTOMETRY, 2001, 46 (04) :222-232
[7]  
Berchuck A, 1998, CLIN CANCER RES, V4, P2433
[8]  
BERCHUCK A, 1990, CANCER RES, V50, P4087
[9]   INTERVAL DEBULKING OF OVARIAN-CANCER - AN INTERIM MEASURE [J].
BEREK, JS .
NEW ENGLAND JOURNAL OF MEDICINE, 1995, 332 (10) :675-677
[10]  
BRYNDORF T, 1995, AM J HUM GENET, V57, P1211